D-1097-2018 Class II Terminated
FDA drug recall D-1097-2018 was initiated by Northwind Pharmaceuticals LLC on Jul 18, 2018 and is designated Class II. Reason for recall: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. The recall status is terminated (terminated Mar 25, 2023). Affected quantity: 2 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 22, 2018
- Initiation Date
- Jul 18, 2018
- Termination Date
- Mar 25, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2 bottles
Product description
Valsartan, 80mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46256. NDC: 51655-0652-52
Reason for recall
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Distribution pattern
Indiana
Code information
Lot: UT48310002, exp 10/31/2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1097-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026